BRIEF RESEARCH REPORT article
Front. Oncol.
Sec. Head and Neck Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1598125
Evidence and Reality: An Observational Study on Pharmacological Outcomes in Advanced Head and Neck Tumors
Provisionally accepted
Consuelo Jordan De Luna1,2*
Anna Esteve1
Olalla Montero Perez1
Ana Clopes1
MARC OLIVA1
Alicia Lozano1
Ricard Mesia1,3- 1Catalan Institute of Oncology, Barcelona, Spain
- 2University of Barcelona, Barcelona, Catalonia, Spain
- 3Germans Trias i Pujol Health Science Research Institute (IGTP), Barcelona, Catalonia, Spain
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The Catalan Institute of Oncology (ICO) is a comprehensive centre for the prevention, diagnosis, and treatment of cancer. At the institute, there is a set of institutional clinical practice guidelines, named ICOPraxis. The field of oncology therapeutics is currently undergoing a transition towards a model of personalised medicine. Institutional clinical guidelines can be more precise in their recommendations by providing a local focus. An evaluation of the utility of clinical guidelines may be conducted through a descriptive analysis of the selection of treatment and the resulting outcome. Retrospective cohort analysis of patients diagnosed with locally-advanced and recurrent/ metastatic HNSCC (stage III to IVc according to 7 and 8th edition TNM-AJCC) and treated at the The Head and Neck Cancer
Keywords: HNSCC, head and neck cancer, Real-life data, Treatment algorithms, decision
Received: 22 Mar 2025; Accepted: 07 Jul 2025.
Copyright: © 2025 Jordan De Luna, Esteve, Montero Perez, Clopes, OLIVA, Lozano and Mesia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Consuelo Jordan De Luna, Catalan Institute of Oncology, Barcelona, Spain
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.